2026-04-13T06:36:45Zhttps://recercat.cat/oai/request

oai:recercat.cat:10230/589962025-12-12T01:57:46Zcom_2072_6col_2072_452952

00925njm 22002777a 4500 dc Albinati, Leone author Bianchi, Agostina author Beekman, Renée author 2024-02-08T07:10:13Z 2024-02-08T07:10:13Z 2023 The author(s) declare financial support was received for the research, authorship, and/or publication of this article. We acknowledge support from the Spanish Ministry of Science and Innovation to the EMBL partnership, from the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. AB is supported by an FPI fellowship from the Spanish Ministry of Science and Innovation (PRE2019-087574). LA received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement number 101034290 and CEX2020-001049-S financed by MCIN/AEI/10.13039/501100011033. RB was supported by a Junior Leader Fellowship from the la Caixa foundation and grants from the Spanish Ministry of Science and Innovation (RTI2018-096359-A-I00) and the European Hematology Association (EHA, Advanced Research Grant), and is supported by grants from the European Research Council (101039265) and the Spanish Ministry of Science and Innovation (PID2021-123635NB-I00). DNA methylation Epigenomics Hematological malignancies Hematopoiesis Single-cell technologies The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond